ArticleAnnals of medicine and surgery (2012)2026

CRISPR-Cas13 and polyphenol nanotherapy: a dual-action frontier against renal fibrosis.

Khadija Rameen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.